71420-79-6

Pharmacokinetic studies of Cefonicid monosodium have shown that high blood concentrations can be achieved rapidly after intravenous and intramuscular injection, and that concomitant use of albendazole prolongs its half-life in the body and reduces the rate of renal excretion[1].

[1] Pitkin D, et al. Kinetics and renal handling of cefonicid[J]. Clinical Pharmacology & Therapeutics, 1981, 30(5): 587-593.